HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Novel Biomarkers of Hepatitis B and Hepatocellular Carcinoma: Clinical Significance of HBcrAg and M2BPGi.

Abstract
The hepatitis B virus (HBV) cannot be removed completely from infected hepatocytes, owing to the presence of intrahepatic covalently closed circular DNA (cccDNA). As chronic hepatitis B (CHB) can progress to cirrhosis and hepatocellular carcinoma (HCC), predicting HCC development in high-risk patients with high viral replicative activity or advanced fibrosis is important. Novel serological biomarkers reflect intrahepatic viral replicative activity or the progression of liver fibrosis, indicating non-invasive alternatives to liver biopsy: (1) Hepatitis B core-related antigen (HBcrAg) correlates with serum HBV DNA and intrahepatic cccDNA. In CHB patients, a decrease in HBcrAg is associated with favorable outcomes. HBcrAg can predict HCC occurrence or recurrence. (2) Measurement of the Mac-2 binding protein glycosylation isomer (M2BPGi) has been introduced for the evaluation of liver fibrosis. An increase in M2BPGi in CHB patients is related to the progression of liver fibrosis and high potential (risk) of HCC development. Here, we describe the clinical applications of HBcrAg and M2BPGi in CHB patients. Additionally, because new potential therapeutic agents that eliminate intrahepatic cccDNA are being developed, monitoring of HBcrAg or M2BPGi might be suitable for evaluating therapeutic effects and the clinical outcomes. In conclusion, these would be appropriate surrogate markers for predicting disease progression.
AuthorsIan Baudi, Takako Inoue, Yasuhito Tanaka
JournalInternational journal of molecular sciences (Int J Mol Sci) Vol. 21 Issue 3 (Jan 31 2020) ISSN: 1422-0067 [Electronic] Switzerland
PMID32023902 (Publication Type: Journal Article, Review)
Chemical References
  • Antigens, Neoplasm
  • Biomarkers
  • Biomarkers, Tumor
  • DNA, Circular
  • Hepatitis B Core Antigens
  • LGALS3BP protein, human
Topics
  • Antigens, Neoplasm (blood)
  • Biomarkers (blood)
  • Biomarkers, Tumor (blood)
  • Carcinoma, Hepatocellular (immunology, metabolism, virology)
  • DNA, Circular (metabolism)
  • Disease Progression
  • Hepatitis B Core Antigens (blood)
  • Hepatitis B virus (genetics, immunology)
  • Hepatitis B, Chronic (immunology, metabolism)
  • Humans
  • Liver Neoplasms (immunology, metabolism, virology)
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: